Dare Bioscience DARE
NASDAQ DARE
$0.85 +0.03 (+4.28%)
As of: Sep 30, 2026 · 1:45 PM EDT

Dare Bioscience, Inc. (DARE) Revenue (2014 - 2026)

Updated

Dare Bioscience (DARE) reported Revenue of $187,546 for Q2 2026, compared with -$21,172 a year earlier.

Analysis

Dare Bioscience, Inc. (DARE) Revenue (2014 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Dare Bioscience's Revenue came in at $1.19 million; for FY2025, it was $1.03 million.

  • Revenue has a five-year compound annual growth rate of -44.7% (FY2020 to FY2025).
  • By year, Revenue came in at $9,784 in FY2024 (-99.7%), $2.81 million in FY2023 (-71.9%) and $10 million in FY2022.
  • Five-year quarterly Revenue spans a low of -$63,647 in Q4 2024 and a high of $10 million in Q2 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 187,546.00
Dec 31, 2025 1.02 Mn
Sep 30, 2025 2,262.00
Jun 30, 2025 -21,172.00
Mar 31, 2025 25,427.00
Dec 31, 2024 -63,647.00
Sep 30, 2024 41,691.00
Jun 30, 2024 22,438.00
Mar 31, 2024 9,302.00
Dec 31, 2023 1.81 Mn
Sep 30, 2023 1.00 Mn
Jun 30, 2022 10.00 Mn
Jun 30, 2017 642,000.00
Mar 31, 2017 1.19 Mn
Dec 31, 2016 766,000.00
Jun 30, 2014 33,000.00
Mar 31, 2014 47,000.00
API Access

Dare Bioscience, Inc. Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=DARE&period=max&api_key=YOUR_API_KEY